Contents

Current Gene Therapy, Volume 10 - Number 5

Editorial [Hot topic: AAV-Mediated Gene Therapy for the Treatment of Retinal Diseases (Guest Editor: Fabienne Rolling)]

, 10(5): 318

Fabienne Rolling


DOI: 10.2174/156652310793180733




AAVs Anatomy: Roadmap for Optimizing Vectors for Translational Success

, 10(5): 319 - 340

Angela M. Mitchell, Sarah C. Nicolson, Jayme K. Warischalk and R. Jude Samulski


DOI: 10.2174/156652310793180706




Manufacturing and Regulatory Strategies for Clinical AAV2-hRPE65

, 10(5): 341 - 349

J. Fraser Wright, Jennifer Wellman and Katherine A. High


DOI: 10.2174/156652310793180715




Retinal Blinding Disorders and Gene Therapy - Molecular and Clinical Aspects

, 10(5): 350 - 370

Birgit Lorenz, Markus Preising and Knut Stieger


DOI: 10.2174/156652310793180698




AAV-Mediated Gene Supply for Treatment of Degenerative and Neovascular Retinal Diseases

, 10(5): 371 - 380

Pasqualina Colella and Alberto Auricchio


DOI: 10.2174/156652310793180670




Gene-Based Therapies for Dominant Retinopathies

, 10(5): 381 - 388

G. Jane Farrar, Arpad Palfi, Paul F.Kenna and Mary O'Reilly


DOI: 10.2174/156652310793180661




Preclinical Studies on Specific Gene Therapy for Recessive Retinal Degenerative Diseases

, 10(5): 389 - 403

Knut Stieger, Christine Chauveau and Fabienne Rolling


DOI: 10.2174/156652310793180689




Major Challenges for Gene Therapy of Thalassemia and Sickle Cell Disease

, 10(5): 404 - 412

Eleni Papanikolaou and Nicholas P. Anagnou


DOI: 10.2174/156652310793180724




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science